World Needs More Than One Winner in the Covid-19 Vaccine Race

World Needs More Than One Winner in the Covid-19 Vaccine Race || NeoDrafts

  • Author : Victor
  • Published : August 04, 2020

World Needs More Than One Winner in the Covid-19 Vaccine Race

This is clear that we need to know how to deal with coronavirus  till an appropriate Covid-19 vaccine is made available. Nearly 180 vaccine candidates have been reported in less than six months and almost three dozen have entered the clinical testing process. The world requires more than one winner in the Covid-19 vaccine race to prevent the coronavirus pandemic.

Vaccine study and development is a systematic method in which pre-clinical tests in labs and rodents are accompanied by three stages of human testing. The first phase of the trial focuses on whether the vaccine content is suitable for human use and whether it contributes to immune reactions (called immunogenicity). The next two steps of clinical trials concentrate on protection, immune response or immunogenicity, and how the vaccine material produces adequate amounts of antibodies to shield the patient from the disease — effectiveness.

  • As we write, some 180 vaccine candidates for the novel coronavirus are currently in various stages of development, and 26 of these proposed vaccines have now entered the process of clinical testing. This is to highlight that, as the coronavirus pandemic threatens to devastate the world, scientists, the scientific community and experts are making concerted efforts to create a vaccine for COVID-19.

World Needs More Than One Winner in the Covid-19 Vaccine Race

  • While the worldwide search for coronavirus vaccination continues, four new vaccines have now passed the final critical stages of clinical trials. Which include vaccine candidates developed by Oxford-AstraZeneca, Chinese group Sinopharm, Chinese pharmaceutical firm Sinovac and the US-based company Moderna Inc. Scientists and medical experts from various parts of the world are commended for their outstanding work in identifying vaccine candidates and initiating clinical trials within 7 months of the outbreak.
  • The novel coronavirus has had an effect on the planet in ways never seen before, impacting 213 countries, infecting 17,208,252 persons around the planet and resulting in almost 7 lakh deaths — all within a period of nearly 7 months. Although the world is waiting for an appropriate COVID vaccine to be given FDA permissions, the bigger picture here-our population-is lacking. Vaccinating a nation of 7.8 billion people would not only need a multinational partnership of suppliers to generate adequate vaccines, but we will need more than 1 vaccine to prevent the coronavirus pandemic.
  • Nonetheless, also with increased attempts by the medical community, the initiation of clinical trials that take about 6 to 9 months longer and regulatory agencies may take their own time to approve a vaccine for mass-scale vaccinations in order to guarantee virtually error-free vaccines.
  • That’s exactly why Fauci, who leads the National Institute of Allergy and Infectious Diseases, said, “There’s going to be more than one contender in the vaccine sector, even though we’re going to need vaccinations for the whole world, billions upon billions of doses, so I’m pretty sure we’re going to have numerous candidates who get it to the goal line, get it approved, and get us far and high.

There is also no certainty that all of these vaccinations will succeed, but if we want to bring an end to this epidemic and misery and get world economies back up quickly, they are our only chance. This means pooling our money to invest in as many vaccines as possible and, if successful, ensuring that we have enough doses to ensure global effects. At the end of the day, this is a global issue that needs a global solution.

For more information, kindly visit our official website –

Share this:

Connect with Us

Recent Post


You may also like :

Leave a Reply

Your email address will not be published. Required fields are marked *